Research graph
References from Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study. Local targets link to admitted publications; unresolved targets remain external evidence.
The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
10.1038/s41375-022-01613-1 · 2022 · External reference
Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states
10.1016/s2352-3026(19)30211-x · 2020 · External reference
Relationship between clone metrics and clinical outcome in clonal cytopenia
10.1182/blood.2021011323 · 2021 · External reference
High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)
10.1038/leu.2015.110 · 2015 · External reference
Myeloid NGS analyses of paired samples from bone marrow and peripheral blood yield concordant results: a prospective cohort analysis of the AGMT Study Group
10.3390/cancers15082305 · 2023 · External reference
Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes
10.1002/ajh.25089 · 2018 · External reference
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
10.1182/blood-2016-10-745273 · 2017 · External reference
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
10.1182/bloodadvances.2020001582 · 2020 · External reference
Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing
10.1182/bloodadvances.2020002306 · 2020 · External reference
NCCN guidelines(R) insights: myelodysplastic syndromes, version 3.2022
10.6004/jnccn.2022.0009 · 2022 · External reference
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes
10.1080/10428194.2019.1616186 · 2019 · External reference
Failure to detect mutations in U2AF1 due to changes in the GRCh38 reference sequence
10.1016/j.jmoldx.2021.10.013 · 2022 · External reference
Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches
10.1186/s13073-020-00761-2 · 2020 · External reference
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
10.1182/blood-2015-03-631747 · 2015 · External reference
Prediction of acute myeloid leukaemia risk in healthy individuals
10.1038/s41586-018-0317-6 · 2018 · External reference
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US National Study
10.1182/bloodadvances.2022009000 · 2023 · External reference
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
10.1038/ncomms12484 · 2016 · External reference
Age-related clonal hematopoiesis associated with adverse outcomes
10.1056/nejmoa1408617 · 2014 · External reference
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
10.1056/nejmoa1701719 · 2017 · External reference
Clonal hematopoiesis in human aging and disease
10.1126/science.aan4673 · 2019 · External reference
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions
10.1182/bloodadvances.2022008578 · 2023 · External reference
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
10.1182/bloodadvances.2023010061 · 2023 · External reference
CHIP, CCUS, and other acronyms: definition, implications, and impact on practice
10.1200/edbk_239083 · 2019 · External reference
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients
2023 · External reference
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
10.1182/blood-2013-03-492884 · 2013 · External reference
Myelodysplastic syndromes, version 2.2017, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2017.0007 · 2017 · External reference
